Find Research Outputs

Search concepts
Selected filters
Abstract/Meeting Abstract

COST-EFFECTIVENESS OF SCREENING AND TREATING CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA EARLY IN LIFE FROM A DUTCH HEALTHCARE PERSPECTIVE

Ademi, Z., Norman, R., Pang, J., Ference, B., Liew, D., Sijbrands, E., Watts, G. & Wiegman, A., Nov 2019, In : Value in Health. 22, Supplement 3, p. S405-S405 1 p., CC1.

Research output: Contribution to journalAbstract/Meeting Abstract

9 Citations (Scopus)

Effectiveness of reverse cascade screeningfor familial hypercholesterolemia in very high risk families in China

Wu, X., Pang, J., Peng, J., Chen, Y., Hong, J., Wang, S., Watts, G. & Lin, J., Aug 2017, In : Atherosclerosis. 263, p. E235-E236 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

FAMILIAL HYPERCHOLESTEROLAEMIA - TIME FOR A GREATER ROLE FOR PRIMARY CARE

Brett, T., Arnold-Reed, D., Ping-Delfos, W. C. S., Condon, C. & Watts, G. F., Aug 2019, In : Atherosclerosis. 287, p. E209-E209 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Isolated Elevation of Lipoprotein(A) is Uncommon Among Patients Admitted to Coronary Care

Ellis, K. L., Pang, J., Bell, D. A., Burnett, J. R., Schultz, C., Hillis, G. S. & Watts, G. F., 2017, In : Heart, Lung and Circulation. 26, Supp. 2, p. S84 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL

Vallejo-Vaz, A. J., Packard, C. J., Ference, B. A., Santos, R. D., Kastelein, J. J., Stein, E. A., Catapano, A. L., Pedersen, T. R., Watts, G. F. & Ray, K. K., Aug 2019, In : Atherosclerosis. 287, p. E6-E6 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

RNA Interference Targeting Hepatic Angiopoietin-Like Protein 3 Results in Prolonged Reductions in Plasma Triglycerides and LDL-C in Human Subjects

Watts, G. F., Schwabe, C., Scott, R., Gladding, P., Sullivan, D. R., Baker, J., Clifton, P., Hamilton, J., Given, B., Melquist, S., Knowles, J., Hegele, R. A. & Ballantyne, C. M., 17 Dec 2019, In : Circulation. 140, 25, p. E987-E988 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Systematic Screening for Familial Hypercholesterolaemia and Elevated Lp (a) in Families

Ellis, K. L., Pang, J., Bell, D. A., Hooper, A. J., Burnett, J. R. & Watts, G. F., 2017, In : Heart, Lung and Circulation. 26, Supp. 2, p. S121-S122

Research output: Contribution to journalAbstract/Meeting Abstract

1 Citation (Scopus)

THE EFFECTS OF OMEGA-3 FATTY ACIDS ON INFLAMMATION, PRO-ATHEROGENIC CYTOKINES AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS

Yong, K., Mori, T., Chew, G., Beilin, L., Puddey, I., Watts, G., Irish, A., Dogra, G., Boudville, N. & Lim, W., Sep 2018, In : Nephrology. 23, p. 45-45 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Article
13 Citations (Scopus)
325 Downloads (Pure)
Open Access
File
Hyperlipoproteinemia Type II
Lipids
Mutation
Early Diagnosis
Xanthomatosis
2 Citations (Scopus)

A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study

Stefanutti, C., Pang, J., Di Giacomo, S., Wu, X., Wang, X., Morozzi, C., Watts, G. F. & Lin, J., Jul 2019, In : Journal of Clinical Lipidology. 13, 4, p. 608-617

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Blood Component Removal
LDL Cholesterol
Survival
Lipoproteins
Blood Platelets
Exercise
Platelet Activation
Brachial Artery
Acute Coronary Syndrome
1 Citation (Scopus)
Hyperlipoproteinemia Type II
Coronary Artery Disease
Life Style
Atherosclerosis
Coronary Vessels
12 Citations (Scopus)

An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study"

Pang, J., Hu, M., Lin, J., Miida, T., Nawawi, H. M., Park, J. E., Wu, X., Ramli, A. S., Kim, N. T., Kwok, S., Gonzalez-Santos, L. E., Su, T-C., Truong, T. H., Soran, H., Yamashita, S., Tomlinson, B. & Watts, G. F., 25 Oct 2017, In : BMJ Open. 7, 10, p. e017817

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Primary Care Physicians
Physicians
Philippines
Vietnam
24 Citations (Scopus)

A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice

Troeung, L., Arnold-Reed, D., Ping-Delfos, W. C. S., Watts, G., Pang, J., Lugonja, M., Bulsara, M., Mortley, D., James, M. & Brett, T., 2016, In : Heart. 102, 11, p. 855-861

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
General Practice
General Practitioners
Lipids
Cholesterol
4 Citations (Scopus)
Hyperlipoproteinemia Type II
Coronary Artery Disease
Fats
Diet
Cholestyramine Resin
6 Citations (Scopus)

An online questionnaire survey of UK general practitioners' knowledge and management of familial hypercholesterolaemia

Kwok, S., Pang, J., Adam, S., Watts, G. F. & Soran, H., 1 Nov 2016, In : BMJ Open. 6, 11, e012691.

Research output: Contribution to journalArticle

Open Access
Knowledge Management
Hyperlipoproteinemia Type II
General Practitioners
Surveys and Questionnaires
England
1 Citation (Scopus)

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity

Verges, B., Adiels, M., Borén, J., Barrett, H., Watts, G., Chan, D., Duvillard, L., Soderlund, S., Matikainen, N., Kahri, J., Lundbom, N., Lundbom, J., Hakkarainen, N., Aho, S., Simoneau-Robin, I. & Taskinen, M. R., 1 Apr 2016, In : Journal of Clinical Endocrinology and Metabolism. 101, 4, p. 1398-1406 9 p.

Research output: Contribution to journalArticle

Open Access
Apolipoprotein A-II
Abdominal Obesity
Apolipoprotein A-I
HDL Lipoproteins
Kinetics
Apoprotein(a)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Plasmas
Kinetics
35 Citations (Scopus)
253 Downloads (Pure)

A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.

Mas, E., Barden, A., Burke, V., Beilin, L., Watts, G., Huang, R-C., Puddey, I., Irish, A. & Mori, T., 13 Apr 2016, In : Clinical Nutrition. 35, 2, p. 331-336 6 p.

Research output: Contribution to journalArticle

Open Access
File
Omega-3 Fatty Acids
Chronic Renal Insufficiency
Randomized Controlled Trials
coenzyme Q10
Lipids
8 Citations (Scopus)

Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey

Banach, M., Mazidi, M., Mikhailidis, D. P., Toth, P. P., Jozwiak, J., Rysz, J. & Watts, G. F., 21 Oct 2018, In : European Heart Journal. 39, 40, p. 3635-3640 6 p.

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Telomere
Confidence Intervals
Nutrition Surveys
Lipids
109 Citations (Scopus)

Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up

Perez De Isla, L., Alonso, R., Watts, G., Mata, N., Saltijeral Cerezo, A., Muñiz, O., Fuentes, F., Diaz-Diaz, J. L., De Andrés, R., Zambón, D., Rubio-Marin, P., Barba-Romero, M. A., Saenz, P., Sanchez Muñoz-Torrero, J. F., Martinez-Faedo, C., Miramontes-Gonzalez, J. P., Badimón, L., Mata, P., Aguado, R., Almagro, F. & 21 othersArrieta, F., Barba, M. Á., Brea, Á., Cepeda, J. M., Díaz, G., Díaz, J. L., Garrido, J. A., Irigoyen, L., Manjón, L., Martin, A., Piedecausa, M., Mauri, M., Miramontes, P., Pereyra, F., Pérez, L., Pintó, X., Pujante, P., Ruiz, E., Sánchez, J. F., Vidal, J. I. & Argüeso, R., 2016, In : Journal of the American College of Cardiology. 67, 11, p. 1278-1285

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
LDL Cholesterol
Registries
Therapeutics
Lipids
5 Citations (Scopus)

Awareness of Pre-diabetes or Diabetes and Associated Factors in People With Psychosis

Foley, D. L. L., Mackinnon, A., Morgan, V. A., Watts, G. F., Castle, D. J. J., Waterreus, A. J. & Galletly, C. A. A., 2016, In : Schizophrenia Bulletin. 42, 5, p. 1280-1289 10 p.

Research output: Contribution to journalArticle

Open Access
10 Citations (Scopus)

A Web-Based Registry for Familial Hypercholesterolaemia

Napier, K. R., Pang, J., Lamont, L., Walker, C. E., Dawkins, H. J., Hunter, A. A., Van Bockxmeer, F., Watts, G. F. & Bellgard, M. I., Jun 2017, In : Heart, Lung and Circulation. 26, 6, p. 635-639 5 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Registries
Australasia
Clinical Audit
New Zealand
12 Citations (Scopus)

Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study

Bos, S., Duvekot, M. H. C., ten Kate, G. J. R., Verhoeven, A. J. M., Mulder, M. T., Schinkel, A. F. L., Nieman, K., Watts, G. F., Sijbrands, E. J. G. & Roeters van Lennep, J. E., 1 Jan 2017, In : Atherosclerosis. 256, p. 62-66 5 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II
Carotid Stenosis
Case-Control Studies
Carotid Artery Diseases
LDL Cholesterol
Monoclonal Antibodies
Cardiovascular Diseases
Guidelines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
14 Citations (Scopus)

Common familial risk factors for schizophrenia and diabetes mellitus

Foley, D. L., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A. & Galletly, C. A., 2016, In : Australian & New Zealand Journal of Psychiatry. 50, 5, p. 488–494

Research output: Contribution to journalArticle

7 Citations (Scopus)

Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

Pang, J., Chan, D. C., Hu, M., Muir, L. A., Kwok, S., Charng, M. J., Florkowski, C. M., George, P. M., Lin, J., Loi, D. D., Marais, A. D., Nawawi, H. M., Gonzalez-Santos, L. E., Su, T. C., Truong, T. H., Santos, R. D., Soran, H., Tomlinson, B., Yamashita, S., Ademi, Z. & 1 othersWatts, G. F., Apr 2019, In : Journal of Clinical Lipidology. 13, 2, p. 287-300

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Delivery of Health Care
Genetic Testing
Education
Developing Countries
7 Citations (Scopus)
Open Access
Apolipoprotein B-48
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoproteins
Triglycerides
Apolipoprotein B-100
25 Citations (Scopus)

Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of head-to-head randomized controlled trials

Sahebkar, A., Simental-Mendía, L. E., Watts, G. F., Serban, M. C., Banach, M. & Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, 3 Feb 2017, In : BMC Medicine. 15, 1, 22.

Research output: Contribution to journalArticle

Open Access
Fibric Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Meta-Analysis
Randomized Controlled Trials
44 Citations (Scopus)

Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics

Watts, G. F., Chan, D. C., Somaratne, R., Wasserman, S. M., Scott, R., Marcovina, S. M. & Barrett, P. H. R., 14 Jul 2018, In : European Heart Journal. 39, 27, p. 2577-2585 9 p.

Research output: Contribution to journalArticle

Lipoprotein(a)
Apoprotein(a)
AMG 145
Proprotein Convertase 9
Apolipoproteins B
25 Citations (Scopus)

Correlates of physical activity in people living with psychotic illness

Suetani, S., Waterreus, A., Morgan, V., Foley, D. L., Galletly, C., Badcock, J. C., Watts, G., Mckinnon, A., Castle, D., Saha, S., Scott, J. G. & Mcgrath, J. J., Aug 2016, In : Acta Psychiatrica Scandinavica. 134, 2, p. 129-137

Research output: Contribution to journalArticle

Comorbidity
Nuclear Family
Loneliness
Unemployment
Psychotic Disorders
34 Citations (Scopus)

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

Lázaro, P., Pérez de Isla, L., Watts, G. F., Alonso, R., Norman, R., Muñiz, O., Fuentes, F., Mata, N., López-Miranda, J., González-Juanatey, J. R., Díaz-Díaz, J. L., Blasco, A. J. & Mata, P., 1 Jan 2017, In : Journal of Clinical Lipidology. 11, 1, p. 260–271

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Cost-Benefit Analysis
Quality-Adjusted Life Years
Genetic Testing
Decision Trees
1 Citation (Scopus)

Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?

Hahn, LA., Mackinnon, A., Foley, D. L., Morgan, V. A., Waterreus, A., Watts, G. F., Castle, D. J., Liu, L. & Galletly, C. A., 17 Nov 2016, In : EARLY INTERVENTION IN PSYCHIATRY. p. 1-7 7 p.

Research output: Contribution to journalArticle

Psychotic Disorders
Morbidity
Mortality
Obesity
Smoking
9 Citations (Scopus)
225 Downloads (Pure)

Cytomegalovirus antibody and vascular pathology in renal transplant recipients

Price, P., Lee, S., Affandi, J., Parsons, R., Naylor, L. H., Watts, G. F. & Irish, A., 1 Jan 2017, In : Journal of Medical Virology. 89, 1, p. 177-181 5 p.

Research output: Contribution to journalArticle

Open Access
File
Cytomegalovirus
Blood Vessels
Pathology
Kidney
Antibodies
9 Citations (Scopus)

Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a)

Vuorio, A., Watts, G. F. & Kovanen, P. T., 2017, In : European Heart Journal. 38, 48, p. 3555-3559 7 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)
135 Downloads (Pure)

Design of the familial hypercholesterolaemia australasia network registry: Creating opportunities for greater international collaboration

Bellgard, M. I., Walker, C. E., Napier, K. R., Lamont, L., Hunter, A. A., Render, L., Radochonski, M., Pang, J., Pedrotti, A., Sullivan, D. R., Kostner, K., Bishop, W., George, P. M., O’brien, R. C., Clifton, P. M., Van Bockxmeer, F. M., Nicholls, S. J., Hamilton-Craig, I., Dawkins, H. J. S. & Watts, G. F., 1 Jan 2017, In : Journal of Atherosclerosis and Thrombosis. 24, 10, p. 1075-1084 10 p.

Research output: Contribution to journalArticle

Open Access
File
Australasia
Hyperlipoproteinemia Type II
Registries
Patient treatment
Blueprints
4 Citations (Scopus)

Detecting familial hypercholesterolemia: The Jack and the Beanstalk principle

Martin, A. C., Allen, C., Pang, J. & Watts, G. F., 16 May 2017, In : Journal of Clinical Lipidology. 11, 2, p. 575-578 4 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Mothers
Hypercholesterolemia
LDL Cholesterol
Fasting
5 Citations (Scopus)
Open Access
Hyperlipoproteinemia Type II
Primary Health Care
New Zealand
Registries
Lipid Metabolism Disorders
1 Citation (Scopus)

Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management

Mancini, G. B. J., Gupta, M., Tsigoulis, M., Cannon, C. P., Genest, J., Ray, K. K., Santos, R. D., Watts, G. F. & Raggi, P., 1 Aug 2017, In : Atherosclerosis. 263, p. 112-118 7 p.

Research output: Contribution to journalArticle

Open Access
Cardiovascular Diseases
Lipids
Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Physicians
65 Citations (Scopus)

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)

Gaudet, D., Watts, G. F., Robinson, J. G., Minini, P., Sasiela, W. J., Edelberg, J., Louie, M. J. & Raal, F. J., 1 Jan 2017, In : American Journal of Cardiology. 119, 1, p. 40-46 7 p.

Research output: Contribution to journalArticle

Open Access
Lipoprotein(a)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
LDL Cholesterol
alirocumab
Hyperlipoproteinemia Type II
5 Citations (Scopus)
Hyperlipoproteinemia Type II
Lipoprotein(a)
LDL Cholesterol
Cholesterol
Lipids
7 Citations (Scopus)
238 Downloads (Pure)

Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes

Pang, J., Chan, D., Hamilton, S., Tenneti, V. S., Watts, G. & Barrett, H., 11 Mar 2016, In : Diabetes, Obesity and Metabolism. 18, 4, p. 384-391 8 p.

Research output: Contribution to journalArticle

Open Access
File
Apolipoprotein B-48
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Niacin
Type 2 Diabetes Mellitus
Lipoproteins
10 Citations (Scopus)
243 Downloads (Pure)
Open Access
File
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II
Elasticity
Omega-3 Fatty Acids
Blood Pressure
6 Citations (Scopus)

Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia

Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 493-501 9 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Therapeutics
Cross-Sectional Studies
Cholesterol
Demography
49 Citations (Scopus)

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Stroes, E., Guyton, J. R., Lepor, N., Civeira, F., Gaudet, D., Watts, G. F., Baccara-Dinet, M. T., Lecorps, G., Manvelian, G., Farnier, M. & ODYSSEY CHOICE II Investigators, 13 Sep 2016, In : Journal of the American Heart Association. 5, 9, p. 138-146

Research output: Contribution to journalArticle

Open Access
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Safety
LDL Cholesterol
Placebos
9 Citations (Scopus)

Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sahebkar, A., Simental-Mendía, L. E., Guerrero-Romero, F., Golledge, J. & Watts, G., 2016, In : Current Pharmaceutical Design. 22, 5, p. 595-608 14 p.

Research output: Contribution to journalArticle

evacetrapib
Lipid A
Meta-Analysis
Randomized Controlled Trials
Safety